Benzinga | Jul 30, 2021 08:27AM EDT

Raymond James Maintains Outperform on DexCom, Raises Price Target to $515

Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $466 to $515.